Skip to main content
Erschienen in: Annals of Surgical Oncology 11/2014

01.10.2014 | Endocrine Tumors

Quality of Life is Modestly Improved in Older Patients with Mild Primary Hyperparathyroidism Postoperatively: Results of a Prospective Multicenter Study

verfasst von: Claire Blanchard, MD, Muriel Mathonnet, MD, PhD, Frédéric Sebag, MD, PhD, Cécile Caillard, MD, Caroline Kubis, Delphine Drui, MD, Elise van Nuvel, PharmD, Catherine Ansquer, MD, Jean-François Henry, MD, Damien Masson, PharmD, PhD, Françoise Kraeber-Bodéré, MD, PhD, Jean-Benoît Hardouin, PhD, Rasa Zarnegar, MD, Antoine Hamy, MD, Eric Mirallié, MD

Erschienen in: Annals of Surgical Oncology | Ausgabe 11/2014

Einloggen, um Zugang zu erhalten

Abstract

Background

The objectives of this study were to evaluate, in mild primary hyperparathyroidism (pHPT) patients, the quality of life (QoL) using the SF-36 questionnaire before and after parathyroidectomy and to detect preoperatively patients who benefit the most from surgery. Most pHPT patients present a mild pHPT defined by calcemia ≤11.4 mg/dL. For these patients, there is debate about whether they should be managed with surveillance, medical therapy, or surgery.

Methods

A prospective multicenter study investigated QoL (SF-36) in patients with mild pHPT before and after parathyroidectomy in four university hospitals. Laboratory results and SF-36 scores were obtained preoperatively and postoperatively (3, 6, and 12 months).

Results

One hundred sixteen patients were included. After surgery, the biochemical cure rate was 98%. Preoperatively, the mental component summary and the physical component summary (PCS) were 38.69 of 100 and 39.53 of 100, respectively. At 1 year, the MCS and the PCS were 41.29 of 100 and 42.03 of 100. The subgroup analysis showed a more significant improvement in patients < 70 years and with calcemia ≥10.4 mg/dL. Postoperative PCS was correlated with age and preoperative PCS: variation = 32.11 − 0.21 × age − 0.4 × preoperative PCS. Men did not improve their MCS postoperatively. Only women with a preoperative MCS <43.6 of 100 showed postoperative improvement.

Conclusions

This study showed, in patients with mild pHPT, an improvement of QoL 1 year after parathyroidectomy. Patients <70 years and with calcemia ≥10.4 mg/dL had a more significant improvement.
Literatur
1.
Zurück zum Zitat Bilezikian JP, Potts JT Jr, Fuleihan GE-H, et al. Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Clin Endocrinol Metab. 2002;87:5353–61.CrossRefPubMed Bilezikian JP, Potts JT Jr, Fuleihan GE-H, et al. Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Clin Endocrinol Metab. 2002;87:5353–61.CrossRefPubMed
2.
Zurück zum Zitat Wermers RA, Khosla S, Atkinson EJ, et al. Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993–2001: an update on the changing epidemiology of the disease. J Bone Miner Res Off. 2006;21:171–7.CrossRef Wermers RA, Khosla S, Atkinson EJ, et al. Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993–2001: an update on the changing epidemiology of the disease. J Bone Miner Res Off. 2006;21:171–7.CrossRef
3.
Zurück zum Zitat Roman SA, Sosa JA, Pietrzak RH, et al. The effects of serum calcium and parathyroid hormone changes on psychological and cognitive function in patients undergoing parathyroidectomy for primary hyperparathyroidism. Ann Surg. 2011;253:131–7.CrossRefPubMed Roman SA, Sosa JA, Pietrzak RH, et al. The effects of serum calcium and parathyroid hormone changes on psychological and cognitive function in patients undergoing parathyroidectomy for primary hyperparathyroidism. Ann Surg. 2011;253:131–7.CrossRefPubMed
4.
Zurück zum Zitat Bollerslev J, Marcocci C, Sosa M, Nordenström J, Bouillon R, Mosekilde L. Current evidence for recommendation of surgery, medical treatment and vitamin D repletion in mild primary hyperparathyroidism. Eur J Endocrinol. 2011;165:851–64.CrossRefPubMed Bollerslev J, Marcocci C, Sosa M, Nordenström J, Bouillon R, Mosekilde L. Current evidence for recommendation of surgery, medical treatment and vitamin D repletion in mild primary hyperparathyroidism. Eur J Endocrinol. 2011;165:851–64.CrossRefPubMed
5.
Zurück zum Zitat Weber T, Eberle J, Messelhäuser U, et al. Parathyroidectomy, elevated depression scores, and suicidal ideation in patients with primary hyperparathyroidism: results of a prospective multicenter study. JAMA Surg. 2013;148:109–15.CrossRefPubMed Weber T, Eberle J, Messelhäuser U, et al. Parathyroidectomy, elevated depression scores, and suicidal ideation in patients with primary hyperparathyroidism: results of a prospective multicenter study. JAMA Surg. 2013;148:109–15.CrossRefPubMed
6.
Zurück zum Zitat Caillard C, Sebag F, Mathonnet M, et al. Prospective evaluation of quality of life (SF-36) and nonspecific symptoms before and after cure of primary hyperparathyroidism (1-year follow-up). Surgery. 2007;141:153–9.CrossRefPubMed Caillard C, Sebag F, Mathonnet M, et al. Prospective evaluation of quality of life (SF-36) and nonspecific symptoms before and after cure of primary hyperparathyroidism (1-year follow-up). Surgery. 2007;141:153–9.CrossRefPubMed
7.
Zurück zum Zitat Bollerslev J, Jansson S, Mollerup CL, et al. Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial. J Clin Endocrinol Metab. 2007;92:1687–92.CrossRefPubMed Bollerslev J, Jansson S, Mollerup CL, et al. Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial. J Clin Endocrinol Metab. 2007;92:1687–92.CrossRefPubMed
8.
Zurück zum Zitat Adler JT, Sippel RS, Schaefer S, Chen H. Surgery improves quality of life in patients with mild hyperparathyroidism. Am J Surg. 2009;197:284–90.CrossRefPubMed Adler JT, Sippel RS, Schaefer S, Chen H. Surgery improves quality of life in patients with mild hyperparathyroidism. Am J Surg. 2009;197:284–90.CrossRefPubMed
9.
Zurück zum Zitat Walker MD, McMahon DJ, Inabnet WB, et al. Neuropsychological features in primary hyperparathyroidism: a prospective study. J Clin Endocrinol Metab. 2009;94:1951–8.CrossRefPubMedCentralPubMed Walker MD, McMahon DJ, Inabnet WB, et al. Neuropsychological features in primary hyperparathyroidism: a prospective study. J Clin Endocrinol Metab. 2009;94:1951–8.CrossRefPubMedCentralPubMed
10.
Zurück zum Zitat Bilezikian JP, Khan AA, Potts JT Jr. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J Clin Endocrinol Metab. 2009;94:335–9.CrossRefPubMedCentralPubMed Bilezikian JP, Khan AA, Potts JT Jr. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J Clin Endocrinol Metab. 2009;94:335–9.CrossRefPubMedCentralPubMed
11.
Zurück zum Zitat NIH conference. Diagnosis and management of asymptomatic primary hyperparathyroidism: consensus development conference statement. Ann Intern Med. 1991;114:593–7.CrossRef NIH conference. Diagnosis and management of asymptomatic primary hyperparathyroidism: consensus development conference statement. Ann Intern Med. 1991;114:593–7.CrossRef
12.
Zurück zum Zitat Calzada-Nocaudie M, Chanson P, Conte-Devolx B, et al. Management of asymptomatic primary hyperparathyroidism: French Society of Endocrinology expert consensus. Ann Endocrinol. 2006;67:7–12.CrossRef Calzada-Nocaudie M, Chanson P, Conte-Devolx B, et al. Management of asymptomatic primary hyperparathyroidism: French Society of Endocrinology expert consensus. Ann Endocrinol. 2006;67:7–12.CrossRef
13.
Zurück zum Zitat Leplège A, Ecosse E, Pouchot J, et al. Le questionnaire MOS SF-36. Manuel de l’utilisateur et guide d’interprétation des scores. ESTEM: Paris; 2001. Leplège A, Ecosse E, Pouchot J, et al. Le questionnaire MOS SF-36. Manuel de l’utilisateur et guide d’interprétation des scores. ESTEM: Paris; 2001.
14.
Zurück zum Zitat Strand V, Singh JA. Improved health-related quality of life with effective disease-modifying antirheumatic drugs: evidence from randomized controlled trials. Am J Manage Care. 2008;14:234–54. Strand V, Singh JA. Improved health-related quality of life with effective disease-modifying antirheumatic drugs: evidence from randomized controlled trials. Am J Manage Care. 2008;14:234–54.
15.
Zurück zum Zitat Amstrup AK, Rejnmark L, Mosekilde L. Patients with surgically cured primary hyperparathyroidism have a reduced quality of life compared with population-based healthy sex-, age-, and season-matched controls. Eur J Endocrinol. 2011;165:753–60.CrossRefPubMed Amstrup AK, Rejnmark L, Mosekilde L. Patients with surgically cured primary hyperparathyroidism have a reduced quality of life compared with population-based healthy sex-, age-, and season-matched controls. Eur J Endocrinol. 2011;165:753–60.CrossRefPubMed
16.
Zurück zum Zitat Egan KR, Adler JT, Olson JE, Chen H. Parathyroidectomy for primary hyperparathyroidism in octogenarians and nonagenarians: a risk-benefit analysis. J Surg Res. 2007;140:194–8.CrossRefPubMed Egan KR, Adler JT, Olson JE, Chen H. Parathyroidectomy for primary hyperparathyroidism in octogenarians and nonagenarians: a risk-benefit analysis. J Surg Res. 2007;140:194–8.CrossRefPubMed
17.
Zurück zum Zitat Rao DS, Phillips ER, Divine GW, Talpos GB. Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism. J Clin Endocrinol Metab. 2004;89:5415–22.CrossRefPubMed Rao DS, Phillips ER, Divine GW, Talpos GB. Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism. J Clin Endocrinol Metab. 2004;89:5415–22.CrossRefPubMed
18.
Zurück zum Zitat Ambrogini E, Cetani F, Cianferotti L, et al. Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial. J Clin Endocrinol Metab. 2007;92:3114–21.CrossRefPubMed Ambrogini E, Cetani F, Cianferotti L, et al. Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial. J Clin Endocrinol Metab. 2007;92:3114–21.CrossRefPubMed
19.
Zurück zum Zitat Kebebew E, Duh Q-Y, Clark OH. Parathyroidectomy for primary hyperparathyroidism in octogenarians and nonagenarians: a plea for early surgical referral. Arch Surg. 2003;138:867–71.CrossRefPubMed Kebebew E, Duh Q-Y, Clark OH. Parathyroidectomy for primary hyperparathyroidism in octogenarians and nonagenarians: a plea for early surgical referral. Arch Surg. 2003;138:867–71.CrossRefPubMed
20.
Zurück zum Zitat Morris GS, Grubbs EG, Hearon CM, et al. Parathyroidectomy improves functional capacity in asymptomatic older patients with primary hyperparathyroidism: a randomized control trial. Ann Surg. 2010;251:832–7.CrossRefPubMed Morris GS, Grubbs EG, Hearon CM, et al. Parathyroidectomy improves functional capacity in asymptomatic older patients with primary hyperparathyroidism: a randomized control trial. Ann Surg. 2010;251:832–7.CrossRefPubMed
21.
Zurück zum Zitat Pasieka JL, Parsons LL, Demeure MJ, et al. Patient-based surgical outcome tool demonstrating alleviation of symptoms following parathyroidectomy in patients with primary hyperparathyroidism. World J Surg. 2002;26:942–9.CrossRefPubMed Pasieka JL, Parsons LL, Demeure MJ, et al. Patient-based surgical outcome tool demonstrating alleviation of symptoms following parathyroidectomy in patients with primary hyperparathyroidism. World J Surg. 2002;26:942–9.CrossRefPubMed
22.
Zurück zum Zitat Keutgen XM, Buitrago D, Filicori F, et al. Calcimimetics versus parathyroidectomy for treatment of primary hyperparathyroidism: retrospective chart analysis of a prospective database. Ann Surg. 2012;255:981–5.CrossRefPubMed Keutgen XM, Buitrago D, Filicori F, et al. Calcimimetics versus parathyroidectomy for treatment of primary hyperparathyroidism: retrospective chart analysis of a prospective database. Ann Surg. 2012;255:981–5.CrossRefPubMed
Metadaten
Titel
Quality of Life is Modestly Improved in Older Patients with Mild Primary Hyperparathyroidism Postoperatively: Results of a Prospective Multicenter Study
verfasst von
Claire Blanchard, MD
Muriel Mathonnet, MD, PhD
Frédéric Sebag, MD, PhD
Cécile Caillard, MD
Caroline Kubis
Delphine Drui, MD
Elise van Nuvel, PharmD
Catherine Ansquer, MD
Jean-François Henry, MD
Damien Masson, PharmD, PhD
Françoise Kraeber-Bodéré, MD, PhD
Jean-Benoît Hardouin, PhD
Rasa Zarnegar, MD
Antoine Hamy, MD
Eric Mirallié, MD
Publikationsdatum
01.10.2014
Verlag
Springer US
Erschienen in
Annals of Surgical Oncology / Ausgabe 11/2014
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-014-3731-5

Weitere Artikel der Ausgabe 11/2014

Annals of Surgical Oncology 11/2014 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.